TO EVALUATE PATTERNS OF DOPPLER WAVEFORM OF HEPATIC VEINS IN EARLY DETECTION OF CIRRHOSIS IN HCV POSITIVE PATIENTS.

Raisa Altaf Malik

Abstract


TO EVALUATE PATTERNS OF DOPPLER WAVEFORM OF HEPATIC VEINS IN EARLY DETECTION OF CIRRHOSIS IN HCV POSITIVE PATIENTS.RABEEA KHAN, RAISA ALTAF, QURATULLAIN, DANIYAL KHALID, HINA NASEER, SADAF NASIR, ⁷UZMA PANHWER.DEPARTMENT OF RADIOLOGY, LIAQUAT NATIONAL HOSPITAL KARACHI. ABSTRACTIntroductionIn patients with well-compensated liver disease, flattening of the Doppler hepatic vein waveform is suggestive of cirrhosis. It is a cheap and non-invasive modality for the diagnosis of cirrhosis. ObjectiveTo evaluate patterns of doppler waveform of hepatic veins in early detection of cirrhosis in HCV positive patients.Study designCross-sectional prospective study.SettingStudy was conducted in Imaging Unit of Radiology Department, Liaquat National Hospital (LNH).Duration of study6 months Subjects and methodsAll patients between 20 – 60 years of age of either gender having HCV for more than six months confirmed on presence of anti-HCV antibodies on enzyme-linked immunosorbent assay (ELISA) were included. Duplex sonographic examination of the hepatic veins was performed and findings were documented on the structured proforma. ResultsMean age of the patients was 49.98 ±13.57 years. Majority of the patients (n=146, 61.3%) were males while 92 (38.7%) were females. On doppler waveform, cirrhosis was detected in 114 (47.9%) of all the patients presenting with hepatitis C. ConclusionThe Doppler wave form pattern of hepatic veins was found to be of cirrhotic pattern in almost half of the patients who had Hepatitis C.KeywordsDoppler wave form, Hepatic veins, Cirrhosis, HCV,

Full Text:

PDF

References


REFERENCES

• Kim WR. Global epidemiology and burden of hepatitis C. Microbes Infect 2002;4(12):1219-25.

• Chak E, Talal AH, Sherman KE, Schiff ER, Saab S. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int 2011;31(8):1090-101.

• Perz JF, Armstrong GL, Farrington LA, Hutin YJF, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45(4):529-38.

• Waheed Y, Shafi T, Safi SZ, Qadri I. Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J Gastroenterol 2009;15(45):5647-53.

• Raja NS, Janjua KA. Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect 2008;41(1):4-8.

• Kinjo N, Nagao Y, Akahoshi T, Masahiro K, Hashimoto N, Uehara H, et al. Hepatic vein waveform and splenomegaly predict improvement of prothrombin time after splenectomy in hepatitis C virus-related cirrhotic patients. Hepatol Res 2013;43(9):933-41.

• Guthrie JD, Sheikh MY, Morrell S, Neal D. A case-control study to compare the likelihood of detecting liver disorders using coincident measures of doppler-derived portal vein pressure gradients, hepatic venous waveforms, and the echogenicity of liver parenchyma. J Diagn Med Sonogr 2012;28(5):211-21.

• Cosgrove D, Lassau N. Imaging of perfusion using ultrasound. Eur J Nucl Med Mol Imaging 2010;37(1):65-85

• Ahmed N, Shahid R, Tanveer S, Shafique M, Latif A. To Determine the Diagnostic Accuracy of Doppler Waveform Pattern of Hepatic Veins in Detection of Chronic Liver Disease in hepatitis C patients Keeping Histopathology as gold Standard. Pak J Radiol. 2015;25(3):89-92.

• Colli A, Cocciolo M, Riva C, Martinez E, Prisco A, Pirola M, et al. Abnormalities of Doppler waveform of the hepatic veins in patients with chronic liver disease: Correlation with histologic findings. Am J Roentgenol 1994;162(4):833-7.

• AZwiebel WJ. Sonographic diagnosis of hepatic vascular disorders. Semin Ultrasound CT MR 1995;16 (1):34–48.

• Killi RM. Doppler sonography of the native liver. Eur J Radiol 1999;32(1):21–35.

• Desser TS, Sze DY, Jeffrey RB. Imaging and intervention in the hepatic veins. AJR Am J Roentgenol 2003;180(6):1583–1591.

• Gorg C, Riera-Knorrenschild J, Dietrich J. Colour Doppler ultrasound flow patterns in the portal venous system. Br J Radiol 2002;75(899):919–929.

• Skandalakis JE, Skandalakis LJ, Skandalakis PN, Mirilas P. Hepatic surgical anatomy. Surg Clin North Am 2004;84(2):413–435.

• Zhuang ZG, Qian LJ, Gong HX. Multidetector computed tomography angiography in the evaluation of potential living donors for liver transplantation: single-center experience in China. Transplant Proc 2008;40(8):2466–2477.

• Erbay N, Raptopoulos V, Pomfret EA, Kamel IR, Kruskal JB. Living donor liver transplantation in adults: vascular variants important in surgical planning for donors and recipients. AJR Am J Roentgenol 2003;181(1):109–114.

• Nakamura S, Tsuzuki T. Surgical anatomy of the hepatic veins and the inferior vena cava. Surg Gynecol Obstet 1981;152(1):43–50.

• Mehran R, Schneider R, Franchebois P. The minor hepatic veins: anatomy and classification. Clin Anat 2000;13(6):416–421.

• Hagen-Ansert SL. Textbook of diagnostic ultrasonography. 6th ed. St Louis, Mo: Mosby Elsevier, 2006; 197.

• Kruskal JB, Newman PA, Sammons LG, Kane RA. Optimizing Doppler and color flow US: application to hepatic sonography. RadioGraphics 2004;24(3): 657–675.

• Rubin JM. Spectral Doppler US. RadioGraphics 1994;14(1):139–150.

• McGahan JP, Goldberg BB, eds. Diagnostic ultrasound: a logical approach. Philadelphia, Pa: Lippincott, 1998; 616.

• Coulden RA, Lomas DJ, Farman P, Britton PD. Doppler ultrasound of the hepatic veins: normal appearances. Clin Radiol 1992;45(4):223–227.

• Bolondi L, Li Bassi S, Gaiani S. Liver cirrhosis: changes of Doppler waveform of hepatic veins. Radiology 1991;178(2):513–516.

• Pedersen JF, Dakhil AZ, Jensen DB, Søndergaard B, Bytzer P. Abnormal hepatic vein Doppler waveform in patients without liver disease. Br J Radiol 2005;78 (927):242–244.

• Abu-Yousef MM. Duplex Doppler sonography of the hepatic vein in tricuspid regurgitation. AJR Am J Roentgenol 1991;156(1):79–83.

• Abu-Yousef MM. Normal and respiratory variations of the hepatic and portal venous duplex Doppler waveforms with simultaneous electrocardiographic correlation. J Ultrasound Med 1992;11(6):263–268.

• Teichgräber UK, Gebel M, Benter T, Manns MP. Effect of respiration, exercise, and food intake on hepatic vein circulation. J Ultrasound Med 1997;16 (8):549–554.

• Shapiro RS, Winsberg F, Maldjian C, StancatoPasik A. Variability of hepatic vein Doppler tracings in normal subjects. J Ultrasound Med 1993;12(12): 701–703.

• Roobottom CA, Hunter JD, Weston MJ, Dubbins PA. Hepatic venous Doppler waveforms: changes in pregnancy. J Clin Ultrasound 1995;23(8):477–482.

• Pekindil G, Varol FG, Yüce MA, Yardim T. Evaluation of hepatic venous pulsatility and portal venous velocity with Doppler ultrasonography during the puerperium. Eur J Radiol 1999;29(3):266–269.

• Chawla Y, Kumar S, Dhiman RK, Suri S, Dilawari JB. Duplex Doppler sonography in patients with Budd-Chiari syndrome. J Gastroenterol Hepatol 1999;14(9):904–907.

• Millener P, Grant EG, Rose S. Color Doppler imaging findings in patients with Budd-Chiari syndrome: correlation with venographic findings. AJR Am J Roentgenol 1993;161(2):307–312.

• Feldstein VA, LaBerge JM. Hepatic vein flow reversal at duplex sonography: a sign of transjugular intrahepatic portosystemic shunt dysfunction. AJR Am J Roentgenol 1994;162(4):839–841.

• Ahmed F, Coll D, Jacobson IM. Imaging. In: Schiff ER, Sorrell MF, Schiff L, Maddrey WC, eds. Schiff’s diseases of the liver. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2007; 83–126.

• Allan PL, Dubbins PA, Poznik MA, McDicken WN. Clinical Doppler ultrasound. London, England: Churchill Livingstone, 2000; 147–148.

• Oguzkurt L, Yildirim T, Torun D, Tercan F, Kizilkilic O, Niron EA. Hepatic vein Doppler waveform in patients with diffuse fatty infiltration of the liver. Eur J Radiol 2005;54(2):253–257.

• Colli A, Cocciolo M, Riva C. Abnormalities of Doppler waveform of the hepatic veins in patients with chronic liver disease: correlation with histologic findings. AJR Am J Roentgenol 1994;162(4): 833–837.

• von Herbay A, Frieling T, Häussinger D. Association between duplex Doppler sonographic flow pattern in right hepatic vein and various liver diseases. J Clin Ultrasound 2001;29(1):25–30.

• Brown BP, Abu-Yousef M, Farner R, LaBrecque D, Gingrich R. Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease. AJR Am J Roentgenol 1990;154(4):721–724.

• Baik SK, Kim JW, Kim HS. Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology 2006;240(2): 574–580.

• Kim MY, Baik SK, Park DH. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study. Liver Int 2007;27(8):1103–1110.

• Parulekar SG, Bree RL. Liver. In: McGahan JP, Goldberg BB, eds. Diagnostic ultrasound: a logical approach. Philadelphia, Pa: Lippincott Williams & Wilkins, 1998; 676–677.

• Shiffman ML. The liver in circulatory failure. In: Schiff ER, Sorrell MF, Schiff L, Maddrey WC, eds. Schiff’s diseases of the liver. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2007; 1185–1198.

• Gorka TS, Gorka W. Doppler sonographic diagnosis of severe portal vein pulsatility in constrictive pericarditis: flow normalization after pericardiectomy. J Clin Ultrasound 1999;27(2):84–88.

• von Bibra H, Schober K, Jenni R, Busch R, Sebening H, Blömer H. Diagnosis of constrictive pericarditis by pulsed Doppler echocardiography of the hepatic vein. Am J Cardiol 1989;63(7):483–488.

• Pande AN, Lilly LS. Pericardial disease. In: Solomon SD, ed. Essential echocardiography: a practical handbook. Totowa, NJ: Humana, 2007; 191–200.

• Saad WE, Lin E, Ormanoski M, Darcy MD, Rubens DJ. Noninvasive imaging of liver transplant complications. Tech Vasc Interv Radiol 2007;10(3):191–206.

• Kok T, Slooff MJ, Thijn CJ. Routine Doppler ultrasound for the detection of clinically unsuspected vascular complications in the early postoperative phase after orthotopic liver transplantation. Transpl Int 1998;11(4):272–276.

• Choi JY, Lee JY, Lee JM. Routine intraoperative Doppler sonography in the evaluation of complications after living-related donor liver transplantation. J Clin Ultrasound 2007;35(9):483–490.

• Ko EY, Kim TK, Kim PN, Kim AY, Ha HK, Lee MG. Hepatic vein stenosis after living donor liver transplantation: evaluation with Doppler US. Radiology 2003;229(3):806–810.

• Jéquier S, Jéquier JC, Hanquinet S, Le Coultre C, Belli DC. Orthotopic liver transplants in children: change in hepatic venous Doppler wave pattern as an indicator of acute rejection. Radiology 2003;226 (1):105–112.

• Britton PD, Lomas DJ, Coulden RA, Farman P, Revell S. The role of hepatic vein Doppler in diagnosing acute rejection following paediatric liver transplantation. Clin Radiol 1992;45(4):228–232.

• Zalasin S, Shapiro RS, Glajchen N, Stancato-Pasik A. Liver transplant rejection: value of hepatic vein Doppler waveform analysis. Abdom Imaging 1998; 23(4):427–430.

• Ripoll C, Groszmann R, Garcia-Tsao G. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481–8.

• Mallet V, Gilgenkrantz H, Serpaggi J. Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatatis C. Ann Intern Med 2008;149: 399–403.

• Conti F, Buonfiglioli F, Scuteri A. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol 2016;65:727–33.

• Anrs T, Co A, Cirvir CO. Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: data from three ANRS cohorts. J Hepatol 2016;65:734–40.

• Kumar M, Kumar A, Hissar S. Hepatic venous pressure gradient as a predictor of ¢ brosis in chronic liver disease because of hepatitis B virus. Liver Int 2008;28:690–8.

• Regev A, Berho M, Jeffers LJ. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614–18.

• de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63:543–5.

• EASL. Management of alcoholic liver disease. J Hepatol 2012;57:399–420.

• Rockey DC, Caldwell SH, Goodman ZD et al. Liver biopsy. Hepatology 2009;49:1017–44.

• Ble M, Procopet B, Miquel R. Transjugular liver biopsy. Clin Liver Dis 2014;18:767–78.

• Kalambokis G, Manousou P, Vibhakorn S. Transjugular liver biopsy: indications, adequacy, quality of specimens, and complications—a systematic review. J Hepatol 2007;47:284–94.

• Saffioti F, Pinzani M. Development and regression of cirrhosis. Dig Dis 2016;34:374–81.

• Kumar M, Sakhuja P, Kumar A. Histological subclassification of cirrhosis based on histological–haemodynamic correlation. Aliment Pharmacol Ther 2008;27:771–9.

• Tsochatzis E, Bruno S, Isgro G. Collagen proportionate area is superior to other histological methods for subclassifying cirrhosis and determining prognosis. J Hepatol 2014;60:948–54.

• Kim MY, Cho MY, Baik SK. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol 2011;55:1004–9.

• Kutami R, Girgrah N, Wanless I. The Laennec grading system for assessment of hepatic fibrosis: validation by correlation with wedged hepatic vein pressure and clinical features. Hepatology 2000;32:407A.

• Kim SU, Jung KS, Lee S. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma. Liver Int 2014;34:1008–17.

• Kim SU, Oh HJ, Wanless IR. The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis. J Hepatol 2012;57:556–63.

• Wanless IR, Nakashima E, Sherman M. Regression of human cirrhosis: morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 2000;124:1599–1607.

• Hytiroglou P, Snover DC, Alves V. Beyond ‘cirrhosis’ A proposal from the International Liver Pathology Study Group. Am J Clin Pathol 2012;137:5–9.

• Bosch J, Abraldes JG, Berzigotti A. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6:573–82.

• Llop E, Berzigotti A, Reig M. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. J Hepatol 2012;56:103–8.

• Rossle M, Blanke P, Fritz B. Free hepatic vein pressure is not useful to calculate the portal pressure gradient in cirrhosis: a morphologic and hemodynamic study. J Vasc Interv Radiol 2016;27:1130–7.

• Silva-Junior G, Baiges A, Turon F. The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique. Hepatology 2015;62:1584–92.

• La Mura V, Abraldes JG, Berzigotti A. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. Hepatology 2010;51:2108–16.

• Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol 2013;7:141–55.

• Blasco A, Forns X, Carrion JA. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology 2006;43: 492–9.

• Garcia-Tsao G, Groszmann RJ, Fisher RL. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419–24.

• Groszmann RJ, Garcia-Tsao G, Bosch J. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254–61.

• Ripoll C, Groszmann RJ, Garcia-Tsao G. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol 2009;50:923–8.

• Berzigotti A, Reig M, Abraldes JG. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology 2015;61:526–36.

• Abraldes JG, Villanueva C, Banares R. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 2008;48:229–36.

• Rincon D, Lo Iacono O, Ripoll C. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis. Aliment Pharmacol Ther 2007;25:841–8.

• Groszmann RJ, Bosch J, Grace ND. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401–7.

• Villanueva C, Balanzo J, Novella M. Nadolol plus isosorbide mononitrate compared with sclerotherapy for prevention of variceal rebleeding. N Engl J Med 1996;334:1624–9.

• Villanueva C, Minana J, Ortiz J. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;345:647–55.

• D’Amico G, Garcia-Pagan JC, Luca A. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006;131: 1611–24.

• Hernandez-Gea V, Aracil C, Colomo A. Development of ascites in compensated cirrhosis with severe portal hypertension treated with b-blockers. Am J Gastroenterol 2012;107:418–27.

• Bureau C, Alric JL, Morales J. ‘A la carte’ treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 2002;1053:1361–6.

• Reiberger T, Ulbrich G, Ferlitsch A. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut 2013;62:1634–41.

• Merkel C, Bolognesi M, Berzigotti A. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria. J Hepatol 2010;52:45–53.

• Mandorfer M, Kozbial K, Schwabl P. Sustained virologic response to interferon-free therapies ameliorates HCVinduced portal hypertension. J Hepatol 2016;65:692–9.

• Lens S, Rincon D, Albillos A. Association between severe portal hypertension and risk of liver decompensation in patients with hepatitis C, regardless of response to antiviral therapy. Clin Gastroenterol Hepatol 2015;13:1846–53

• de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762–8.

• Rudler M, Benosman H, Lebray P. Screening for esophageal varices in patients newly diagnosed in 2011: 84% of upper gastrointestinal endoscopies are futile. Hepatology 2011;54(Suppl):935A.

• Child C, Turcotte J. Surgery and portal hypertension. In: C Child (ed.). The Liver and Portal Hypertension. Philadelphia: W. B. Saunders Co., 1964, 50.

• Lackner C, Struber G, Liegl B. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005;41:1376–82.

• Macıas J, Giron-Gonz alez JA, Gonz alez-Serrano M. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple noninvasive indexes. Gut 2006;55:409–14.

• Castera L, Le Bail B, Roudot-Thoraval F. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009;50:59–68.

• Thabut D, Imbert-Bismut F, Cazals-Hatem D. Relationship between the Fibrotest and portal hypertension in patients with liver disease. Aliment Pharmacol Ther 2007;26:359–68.

• Berzigotti A, Seijo S, Arena U. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 2013;144: 102–11.

• Sheth SG, Flamm SL, Gordon FD CS. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998;93:44–8.

• Wai CT, Greenson JK, Fontana RJ. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518–26.

• Corpechot C, Carrat F, Poujol-Robert A. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology 2012;56:198–208.

• Lok ASF, Ghany MG, Goodman ZD. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005;42:282–92.

• Procopet B, Cristea VM, Robic MA. Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension. Dig Liver Dis 2015;47:411–16.

• Corpechot C, Carrat F, Poujol-Robert A. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology 2012;56:198–208.

• Sterling RK, Lissen E, Clumeck N. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43: 1317–25.

• Kim BK, Kim DY, Park JY. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int 2010;30:546–53.

• Floreani A, Cazzagon N, Martines D. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. Dig Liver Dis 2011;43:887–92.

• Lucidarme D, Foucher J, Le Bail B. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009;49:1083–9.

• Naveau S, Gaude´ G, Asnacios A. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009;49:97–105.

• Zarski J-P, Sturm N, Guechot J. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol 2012;56:55–62.

• Lichtinghagen R, Pietsch D, Bantel H. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values. J Hepatol 2013;59:236–42.

• Qamar A a, Grace ND, Groszmann RJ. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol 2009;7:689–95.

• Kamath PS, Wiesner RH, Malinchoc M. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–70.

• Nunes D, Fleming C, Offner G. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol 2010;105:1346–53.

• Vergniol J, Foucher J, Terrebonne E. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011;140:1970–9.

• Bamber J, Cosgrove D, Dietrich CF. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med 2013;34:169–84.

• Shiina T, Nightingale KR, Palmeri ML. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 1: Basic principles and terminology. UltrasoundMed Biol 2015;41:1126–47.

• Cosgrove D, Piscaglia F, Bamber J. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications. Ultraschall Med 2013;34:238–53.

• Ferraioli G, Filice C, Castera L. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 3: Liver. Ultrasound Med Biol 2015;41: 1161–79.

• Friedrich-Rust M, Ong MF, Martens S. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960–74.

• EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015;63:237–64.

• Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012;142: 1293–1302.

• Shi KQ, Fan YC, Pan ZZ. Transient elastography: a metaanalysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int 2013;33:62–71.

• You MW, Kim KW, Pyo J. A meta-analysis for the diagnostic performance of transient elastography for clinically significant portal hypertension. Ultrasound Med Biol 2016;43:59–68.

• Singh S, Fujii LL, Murad MH. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013;11:1573–84.

• Castera L, Pinzani M, Bosch J. Non invasive evaluation of portal hypertension using transient elastography. J Hepatol 2012;56:696–703.

• Vizzutti F, Arena U, Romanelli RG. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007;45:1290–7.

• Friedrich-Rust M, Nierhoff J, Lupsor M. Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 2012;19:e212–19.

• 82. Feng JC, Li J, Wu XW. Diagnostic accuracy of supersonic shear imaging for staging of liver fibrosis: a meta-analysis. J Ultrasound Med 2016;35:329–39.

• Berzigotti A. (2017) Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol, Published online: February 13, 2017. DOI: 10.1016/j.jhep.2017.02.003.

• Mejias M, Garcia-Pras E, Gallego J. Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension. J Hepatol 2010;52:529–39.

• Ma X, Wang L, Wu H. Spleen stiffness is superior to liver stiffness for predicting esophageal varices in chronic liver disease: a meta-analysis. PLoS One 2016;11:1–15.

• Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging 2013;37:544–55.

• Godfrey EM, Mannelli L, Griffin N. Magnetic resonance elastography in the diagnosis of hepatic fibrosis. Semin Ultrasound CT MR 2013;34:81–8.

• Cui J, Heba E, Hernandez C. Magnetic resonance elastography is superior to acoustic radiation force impulse for the diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: a prospective study. Hepatology 2016;63:453–61.

• Imajo K, Kessoku T, Honda Y. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 2016;150:626–37.e7.

• Ronot M, Lambert S, Elkrief L. Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis. Eur Radiol 2014;24:1394–1402.

• Margini C, Berzigotti A. Portal vein thrombosis: The role of imaging in the clinical setting. Dig Liver Dis 2016;49:113–20.

• Simonovsky V. The diagnosis of cirrhosis by high resolution ultrasound of the liver surface. Br J Radiol 1999;72:29–34.

• Berzigotti A, Abraldes JG, Tandon P. Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis. J Hepatol 2010;52:846–53.

• Gaiani S, Gramantieri L, Venturoli N. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997;27:979–85.

• Berzigotti A, Piscaglia F. Ultrasound in portal hypertension—Part 1. Ultraschall Med 2011;32:548–71.

• Berzigotti A, Piscaglia F. Ultrasound in portal hypertension—Part 2—and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension. Ultraschall Med 2012;33:8–32.

• Abraldes JG, Gilabert R, Turnes J. Utility of color Doppler ultrasonography predicting TIPS dysfunction. Am J Gastroenterol 2005;100:2696–2701.

• Brancatelli G, Federle MP, Ambrosini R. Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 2007;61:57–69.

• Smith AD, Branch CR, Zand K. Liver surface nodularity quantification from routine ct images as a biomarker for detection and evaluation of cirrhosis. Radiology 2016;280:151542.

• de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol 2008;49:520–7.

• McAvoy NC, Semple S, Richards JMJ. Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis. Aliment Pharmacol Ther 2016;43:947–54.

• Materne R, van Beers BE, Smith AM. Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci (Lond) 2000;99:517–25.

• Van Beers BE, Materne R, Annet L. Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrast-enhanced MRI in the rabbit. Magn Reson Med 2003;49:692–9.

• Annet L, Materne R, Danse E. Measured with MR Imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003;2:409–14.

• Gouya H, Grabar S, Vignaux O. Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2Dcine phase-contrast magnetic resonance imaging. Eur Radiol 2016;26:1981–90.

• Palaniyappan N, Cox E, Bradley C. Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging. J Hepatol 2016;65:1131–9.

REFERENCES

• Kim WR. Global epidemiology and burden of hepatitis C. Microbes Infect 2002;4(12):1219-25.

• Chak E, Talal AH, Sherman KE, Schiff ER, Saab S. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int 2011;31(8):1090-101.

• Perz JF, Armstrong GL, Farrington LA, Hutin YJF, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45(4):529-38.

• Waheed Y, Shafi T, Safi SZ, Qadri I. Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J Gastroenterol 2009;15(45):5647-53.

• Raja NS, Janjua KA. Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect 2008;41(1):4-8.

• Kinjo N, Nagao Y, Akahoshi T, Masahiro K, Hashimoto N, Uehara H, et al. Hepatic vein waveform and splenomegaly predict improvement of prothrombin time after splenectomy in hepatitis C virus-related cirrhotic patients. Hepatol Res 2013;43(9):933-41.

• Guthrie JD, Sheikh MY, Morrell S, Neal D. A case-control study to compare the likelihood of detecting liver disorders using coincident measures of doppler-derived portal vein pressure gradients, hepatic venous waveforms, and the echogenicity of liver parenchyma. J Diagn Med Sonogr 2012;28(5):211-21.

• Cosgrove D, Lassau N. Imaging of perfusion using ultrasound. Eur J Nucl Med Mol Imaging 2010;37(1):65-85

• Ahmed N, Shahid R, Tanveer S, Shafique M, Latif A. To Determine the Diagnostic Accuracy of Doppler Waveform Pattern of Hepatic Veins in Detection of Chronic Liver Disease in hepatitis C patients Keeping Histopathology as gold Standard. Pak J Radiol. 2015;25(3):89-92.

• Colli A, Cocciolo M, Riva C, Martinez E, Prisco A, Pirola M, et al. Abnormalities of Doppler waveform of the hepatic veins in patients with chronic liver disease: Correlation with histologic findings. Am J Roentgenol 1994;162(4):833-7.

• AZwiebel WJ. Sonographic diagnosis of hepatic vascular disorders. Semin Ultrasound CT MR 1995;16 (1):34–48.

• Killi RM. Doppler sonography of the native liver. Eur J Radiol 1999;32(1):21–35.

• Desser TS, Sze DY, Jeffrey RB. Imaging and intervention in the hepatic veins. AJR Am J Roentgenol 2003;180(6):1583–1591.

• Gorg C, Riera-Knorrenschild J, Dietrich J. Colour Doppler ultrasound flow patterns in the portal venous system. Br J Radiol 2002;75(899):919–929.

• Skandalakis JE, Skandalakis LJ, Skandalakis PN, Mirilas P. Hepatic surgical anatomy. Surg Clin North Am 2004;84(2):413–435.

• Zhuang ZG, Qian LJ, Gong HX. Multidetector computed tomography angiography in the evaluation of potential living donors for liver transplantation: single-center experience in China. Transplant Proc 2008;40(8):2466–2477.

• Erbay N, Raptopoulos V, Pomfret EA, Kamel IR, Kruskal JB. Living donor liver transplantation in adults: vascular variants important in surgical planning for donors and recipients. AJR Am J Roentgenol 2003;181(1):109–114.

• Nakamura S, Tsuzuki T. Surgical anatomy of the hepatic veins and the inferior vena cava. Surg Gynecol Obstet 1981;152(1):43–50.

• Mehran R, Schneider R, Franchebois P. The minor hepatic veins: anatomy and classification. Clin Anat 2000;13(6):416–421.

• Hagen-Ansert SL. Textbook of diagnostic ultrasonography. 6th ed. St Louis, Mo: Mosby Elsevier, 2006; 197.

• Kruskal JB, Newman PA, Sammons LG, Kane RA. Optimizing Doppler and color flow US: application to hepatic sonography. RadioGraphics 2004;24(3): 657–675.

• Rubin JM. Spectral Doppler US. RadioGraphics 1994;14(1):139–150.

• McGahan JP, Goldberg BB, eds. Diagnostic ultrasound: a logical approach. Philadelphia, Pa: Lippincott, 1998; 616.

• Coulden RA, Lomas DJ, Farman P, Britton PD. Doppler ultrasound of the hepatic veins: normal appearances. Clin Radiol 1992;45(4):223–227.

• Bolondi L, Li Bassi S, Gaiani S. Liver cirrhosis: changes of Doppler waveform of hepatic veins. Radiology 1991;178(2):513–516.

• Pedersen JF, Dakhil AZ, Jensen DB, Søndergaard B, Bytzer P. Abnormal hepatic vein Doppler waveform in patients without liver disease. Br J Radiol 2005;78 (927):242–244.

• Abu-Yousef MM. Duplex Doppler sonography of the hepatic vein in tricuspid regurgitation. AJR Am J Roentgenol 1991;156(1):79–83.

• Abu-Yousef MM. Normal and respiratory variations of the hepatic and portal venous duplex Doppler waveforms with simultaneous electrocardiographic correlation. J Ultrasound Med 1992;11(6):263–268.

• Teichgräber UK, Gebel M, Benter T, Manns MP. Effect of respiration, exercise, and food intake on hepatic vein circulation. J Ultrasound Med 1997;16 (8):549–554.

• Shapiro RS, Winsberg F, Maldjian C, StancatoPasik A. Variability of hepatic vein Doppler tracings in normal subjects. J Ultrasound Med 1993;12(12): 701–703.

• Roobottom CA, Hunter JD, Weston MJ, Dubbins PA. Hepatic venous Doppler waveforms: changes in pregnancy. J Clin Ultrasound 1995;23(8):477–482.

• Pekindil G, Varol FG, Yüce MA, Yardim T. Evaluation of hepatic venous pulsatility and portal venous velocity with Doppler ultrasonography during the puerperium. Eur J Radiol 1999;29(3):266–269.

• Chawla Y, Kumar S, Dhiman RK, Suri S, Dilawari JB. Duplex Doppler sonography in patients with Budd-Chiari syndrome. J Gastroenterol Hepatol 1999;14(9):904–907.

• Millener P, Grant EG, Rose S. Color Doppler imaging findings in patients with Budd-Chiari syndrome: correlation with venographic findings. AJR Am J Roentgenol 1993;161(2):307–312.

• Feldstein VA, LaBerge JM. Hepatic vein flow reversal at duplex sonography: a sign of transjugular intrahepatic portosystemic shunt dysfunction. AJR Am J Roentgenol 1994;162(4):839–841.

• Ahmed F, Coll D, Jacobson IM. Imaging. In: Schiff ER, Sorrell MF, Schiff L, Maddrey WC, eds. Schiff’s diseases of the liver. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2007; 83–126.

• Allan PL, Dubbins PA, Poznik MA, McDicken WN. Clinical Doppler ultrasound. London, England: Churchill Livingstone, 2000; 147–148.

• Oguzkurt L, Yildirim T, Torun D, Tercan F, Kizilkilic O, Niron EA. Hepatic vein Doppler waveform in patients with diffuse fatty infiltration of the liver. Eur J Radiol 2005;54(2):253–257.

• Colli A, Cocciolo M, Riva C. Abnormalities of Doppler waveform of the hepatic veins in patients with chronic liver disease: correlation with histologic findings. AJR Am J Roentgenol 1994;162(4): 833–837.

• von Herbay A, Frieling T, Häussinger D. Association between duplex Doppler sonographic flow pattern in right hepatic vein and various liver diseases. J Clin Ultrasound 2001;29(1):25–30.

• Brown BP, Abu-Yousef M, Farner R, LaBrecque D, Gingrich R. Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease. AJR Am J Roentgenol 1990;154(4):721–724.

• Baik SK, Kim JW, Kim HS. Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology 2006;240(2): 574–580.

• Kim MY, Baik SK, Park DH. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study. Liver Int 2007;27(8):1103–1110.

• Parulekar SG, Bree RL. Liver. In: McGahan JP, Goldberg BB, eds. Diagnostic ultrasound: a logical approach. Philadelphia, Pa: Lippincott Williams & Wilkins, 1998; 676–677.

• Shiffman ML. The liver in circulatory failure. In: Schiff ER, Sorrell MF, Schiff L, Maddrey WC, eds. Schiff’s diseases of the liver. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2007; 1185–1198.

• Gorka TS, Gorka W. Doppler sonographic diagnosis of severe portal vein pulsatility in constrictive pericarditis: flow normalization after pericardiectomy. J Clin Ultrasound 1999;27(2):84–88.

• von Bibra H, Schober K, Jenni R, Busch R, Sebening H, Blömer H. Diagnosis of constrictive pericarditis by pulsed Doppler echocardiography of the hepatic vein. Am J Cardiol 1989;63(7):483–488.

• Pande AN, Lilly LS. Pericardial disease. In: Solomon SD, ed. Essential echocardiography: a practical handbook. Totowa, NJ: Humana, 2007; 191–200.

• Saad WE, Lin E, Ormanoski M, Darcy MD, Rubens DJ. Noninvasive imaging of liver transplant complications. Tech Vasc Interv Radiol 2007;10(3):191–206.

• Kok T, Slooff MJ, Thijn CJ. Routine Doppler ultrasound for the detection of clinically unsuspected vascular complications in the early postoperative phase after orthotopic liver transplantation. Transpl Int 1998;11(4):272–276.

• Choi JY, Lee JY, Lee JM. Routine intraoperative Doppler sonography in the evaluation of complications after living-related donor liver transplantation. J Clin Ultrasound 2007;35(9):483–490.

• Ko EY, Kim TK, Kim PN, Kim AY, Ha HK, Lee MG. Hepatic vein stenosis after living donor liver transplantation: evaluation with Doppler US. Radiology 2003;229(3):806–810.

• Jéquier S, Jéquier JC, Hanquinet S, Le Coultre C, Belli DC. Orthotopic liver transplants in children: change in hepatic venous Doppler wave pattern as an indicator of acute rejection. Radiology 2003;226 (1):105–112.

• Britton PD, Lomas DJ, Coulden RA, Farman P, Revell S. The role of hepatic vein Doppler in diagnosing acute rejection following paediatric liver transplantation. Clin Radiol 1992;45(4):228–232.

• Zalasin S, Shapiro RS, Glajchen N, Stancato-Pasik A. Liver transplant rejection: value of hepatic vein Doppler waveform analysis. Abdom Imaging 1998; 23(4):427–430.

• Ripoll C, Groszmann R, Garcia-Tsao G. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481–8.

• Mallet V, Gilgenkrantz H, Serpaggi J. Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatatis C. Ann Intern Med 2008;149: 399–403.

• Conti F, Buonfiglioli F, Scuteri A. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol 2016;65:727–33.

• Anrs T, Co A, Cirvir CO. Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: data from three ANRS cohorts. J Hepatol 2016;65:734–40.

• Kumar M, Kumar A, Hissar S. Hepatic venous pressure gradient as a predictor of ¢ brosis in chronic liver disease because of hepatitis B virus. Liver Int 2008;28:690–8.

• Regev A, Berho M, Jeffers LJ. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614–18.

• de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63:543–5.

• EASL. Management of alcoholic liver disease. J Hepatol 2012;57:399–420.

• Rockey DC, Caldwell SH, Goodman ZD et al. Liver biopsy. Hepatology 2009;49:1017–44.

• Ble M, Procopet B, Miquel R. Transjugular liver biopsy. Clin Liver Dis 2014;18:767–78.

• Kalambokis G, Manousou P, Vibhakorn S. Transjugular liver biopsy: indications, adequacy, quality of specimens, and complications—a systematic review. J Hepatol 2007;47:284–94.

• Saffioti F, Pinzani M. Development and regression of cirrhosis. Dig Dis 2016;34:374–81.

• Kumar M, Sakhuja P, Kumar A. Histological subclassification of cirrhosis based on histological–haemodynamic correlation. Aliment Pharmacol Ther 2008;27:771–9.

• Tsochatzis E, Bruno S, Isgro G. Collagen proportionate area is superior to other histological methods for subclassifying cirrhosis and determining prognosis. J Hepatol 2014;60:948–54.

• Kim MY, Cho MY, Baik SK. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol 2011;55:1004–9.

• Kutami R, Girgrah N, Wanless I. The Laennec grading system for assessment of hepatic fibrosis: validation by correlation with wedged hepatic vein pressure and clinical features. Hepatology 2000;32:407A.

• Kim SU, Jung KS, Lee S. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma. Liver Int 2014;34:1008–17.

• Kim SU, Oh HJ, Wanless IR. The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis. J Hepatol 2012;57:556–63.

• Wanless IR, Nakashima E, Sherman M. Regression of human cirrhosis: morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 2000;124:1599–1607.

• Hytiroglou P, Snover DC, Alves V. Beyond ‘cirrhosis’ A proposal from the International Liver Pathology Study Group. Am J Clin Pathol 2012;137:5–9.

• Bosch J, Abraldes JG, Berzigotti A. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6:573–82.

• Llop E, Berzigotti A, Reig M. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. J Hepatol 2012;56:103–8.

• Rossle M, Blanke P, Fritz B. Free hepatic vein pressure is not useful to calculate the portal pressure gradient in cirrhosis: a morphologic and hemodynamic study. J Vasc Interv Radiol 2016;27:1130–7.

• Silva-Junior G, Baiges A, Turon F. The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique. Hepatology 2015;62:1584–92.

• La Mura V, Abraldes JG, Berzigotti A. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. Hepatology 2010;51:2108–16.

• Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol 2013;7:141–55.

• Blasco A, Forns X, Carrion JA. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology 2006;43: 492–9.

• Garcia-Tsao G, Groszmann RJ, Fisher RL. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419–24.

• Groszmann RJ, Garcia-Tsao G, Bosch J. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254–61.

• Ripoll C, Groszmann RJ, Garcia-Tsao G. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol 2009;50:923–8.

• Berzigotti A, Reig M, Abraldes JG. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology 2015;61:526–36.

• Abraldes JG, Villanueva C, Banares R. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 2008;48:229–36.

• Rincon D, Lo Iacono O, Ripoll C. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis. Aliment Pharmacol Ther 2007;25:841–8.

• Groszmann RJ, Bosch J, Grace ND. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401–7.

• Villanueva C, Balanzo J, Novella M. Nadolol plus isosorbide mononitrate compared with sclerotherapy for prevention of variceal rebleeding. N Engl J Med 1996;334:1624–9.

• Villanueva C, Minana J, Ortiz J. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;345:647–55.

• D’Amico G, Garcia-Pagan JC, Luca A. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006;131: 1611–24.

• Hernandez-Gea V, Aracil C, Colomo A. Development of ascites in compensated cirrhosis with severe portal hypertension treated with b-blockers. Am J Gastroenterol 2012;107:418–27.

• Bureau C, Alric JL, Morales J. ‘A la carte’ treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 2002;1053:1361–6.

• Reiberger T, Ulbrich G, Ferlitsch A. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut 2013;62:1634–41.

• Merkel C, Bolognesi M, Berzigotti A. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria. J Hepatol 2010;52:45–53.

• Mandorfer M, Kozbial K, Schwabl P. Sustained virologic response to interferon-free therapies ameliorates HCVinduced portal hypertension. J Hepatol 2016;65:692–9.

• Lens S, Rincon D, Albillos A. Association between severe portal hypertension and risk of liver decompensation in patients with hepatitis C, regardless of response to antiviral therapy. Clin Gastroenterol Hepatol 2015;13:1846–53

• de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762–8.

• Rudler M, Benosman H, Lebray P. Screening for esophageal varices in patients newly diagnosed in 2011: 84% of upper gastrointestinal endoscopies are futile. Hepatology 2011;54(Suppl):935A.

• Child C, Turcotte J. Surgery and portal hypertension. In: C Child (ed.). The Liver and Portal Hypertension. Philadelphia: W. B. Saunders Co., 1964, 50.

• Lackner C, Struber G, Liegl B. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005;41:1376–82.

• Macıas J, Giron-Gonz alez JA, Gonz alez-Serrano M. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple noninvasive indexes. Gut 2006;55:409–14.

• Castera L, Le Bail B, Roudot-Thoraval F. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009;50:59–68.

• Thabut D, Imbert-Bismut F, Cazals-Hatem D. Relationship between the Fibrotest and portal hypertension in patients with liver disease. Aliment Pharmacol Ther 2007;26:359–68.

• Berzigotti A, Seijo S, Arena U. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 2013;144: 102–11.

• Sheth SG, Flamm SL, Gordon FD CS. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998;93:44–8.

• Wai CT, Greenson JK, Fontana RJ. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518–26.

• Corpechot C, Carrat F, Poujol-Robert A. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology 2012;56:198–208.

• Lok ASF, Ghany MG, Goodman ZD. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005;42:282–92.

• Procopet B, Cristea VM, Robic MA. Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension. Dig Liver Dis 2015;47:411–16.

• Corpechot C, Carrat F, Poujol-Robert A. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology 2012;56:198–208.

• Sterling RK, Lissen E, Clumeck N. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43: 1317–25.

• Kim BK, Kim DY, Park JY. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int 2010;30:546–53.

• Floreani A, Cazzagon N, Martines D. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. Dig Liver Dis 2011;43:887–92.

• Lucidarme D, Foucher J, Le Bail B. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009;49:1083–9.

• Naveau S, Gaude´ G, Asnacios A. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009;49:97–105.

• Zarski J-P, Sturm N, Guechot J. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol 2012;56:55–62.

• Lichtinghagen R, Pietsch D, Bantel H. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values. J Hepatol 2013;59:236–42.

• Qamar A a, Grace ND, Groszmann RJ. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol 2009;7:689–95.

• Kamath PS, Wiesner RH, Malinchoc M. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–70.

• Nunes D, Fleming C, Offner G. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol 2010;105:1346–53.

• Vergniol J, Foucher J, Terrebonne E. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011;140:1970–9.

• Bamber J, Cosgrove D, Dietrich CF. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med 2013;34:169–84.

• Shiina T, Nightingale KR, Palmeri ML. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 1: Basic principles and terminology. UltrasoundMed Biol 2015;41:1126–47.

• Cosgrove D, Piscaglia F, Bamber J. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications. Ultraschall Med 2013;34:238–53.

• Ferraioli G, Filice C, Castera L. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 3: Liver. Ultrasound Med Biol 2015;41: 1161–79.

• Friedrich-Rust M, Ong MF, Martens S. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960–74.

• EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015;63:237–64.

• Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012;142: 1293–1302.

• Shi KQ, Fan YC, Pan ZZ. Transient elastography: a metaanalysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int 2013;33:62–71.

• You MW, Kim KW, Pyo J. A meta-analysis for the diagnostic performance of transient elastography for clinically significant portal hypertension. Ultrasound Med Biol 2016;43:59–68.

• Singh S, Fujii LL, Murad MH. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013;11:1573–84.

• Castera L, Pinzani M, Bosch J. Non invasive evaluation of portal hypertension using transient elastography. J Hepatol 2012;56:696–703.

• Vizzutti F, Arena U, Romanelli RG. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007;45:1290–7.

• Friedrich-Rust M, Nierhoff J, Lupsor M. Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 2012;19:e212–19.

• 82. Feng JC, Li J, Wu XW. Diagnostic accuracy of supersonic shear imaging for staging of liver fibrosis: a meta-analysis. J Ultrasound Med 2016;35:329–39.

• Berzigotti A. (2017) Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol, Published online: February 13, 2017. DOI: 10.1016/j.jhep.2017.02.003.

• Mejias M, Garcia-Pras E, Gallego J. Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension. J Hepatol 2010;52:529–39.

• Ma X, Wang L, Wu H. Spleen stiffness is superior to liver stiffness for predicting esophageal varices in chronic liver disease: a meta-analysis. PLoS One 2016;11:1–15.

• Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging 2013;37:544–55.

• Godfrey EM, Mannelli L, Griffin N. Magnetic resonance elastography in the diagnosis of hepatic fibrosis. Semin Ultrasound CT MR 2013;34:81–8.

• Cui J, Heba E, Hernandez C. Magnetic resonance elastography is superior to acoustic radiation force impulse for the diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: a prospective study. Hepatology 2016;63:453–61.

• Imajo K, Kessoku T, Honda Y. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 2016;150:626–37.e7.

• Ronot M, Lambert S, Elkrief L. Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis. Eur Radiol 2014;24:1394–1402.

• Margini C, Berzigotti A. Portal vein thrombosis: The role of imaging in the clinical setting. Dig Liver Dis 2016;49:113–20.

• Simonovsky V. The diagnosis of cirrhosis by high resolution ultrasound of the liver surface. Br J Radiol 1999;72:29–34.

• Berzigotti A, Abraldes JG, Tandon P. Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis. J Hepatol 2010;52:846–53.

• Gaiani S, Gramantieri L, Venturoli N. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997;27:979–85.

• Berzigotti A, Piscaglia F. Ultrasound in portal hypertension—Part 1. Ultraschall Med 2011;32:548–71.

• Berzigotti A, Piscaglia F. Ultrasound in portal hypertension—Part 2—and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension. Ultraschall Med 2012;33:8–32.

• Abraldes JG, Gilabert R, Turnes J. Utility of color Doppler ultrasonography predicting TIPS dysfunction. Am J Gastroenterol 2005;100:2696–2701.

• Brancatelli G, Federle MP, Ambrosini R. Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 2007;61:57–69.

• Smith AD, Branch CR, Zand K. Liver surface nodularity quantification from routine ct images as a biomarker for detection and evaluation of cirrhosis. Radiology 2016;280:151542.

• de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol 2008;49:520–7.

• McAvoy NC, Semple S, Richards JMJ. Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis. Aliment Pharmacol Ther 2016;43:947–54.

• Materne R, van Beers BE, Smith AM. Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci (Lond) 2000;99:517–25.

• Van Beers BE, Materne R, Annet L. Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrast-enhanced MRI in the rabbit. Magn Reson Med 2003;49:692–9.

• Annet L, Materne R, Danse E. Measured with MR Imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003;2:409–14.

• Gouya H, Grabar S, Vignaux O. Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2Dcine phase-contrast magnetic resonance imaging. Eur Radiol 2016;26:1981–90.

• Palaniyappan N, Cox E, Bradley C. Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging. J Hepatol 2016;65:1131–9.

REFERENCES

• Kim WR. Global epidemiology and burden of hepatitis C. Microbes Infect 2002;4(12):1219-25.

• Chak E, Talal AH, Sherman KE, Schiff ER, Saab S. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int 2011;31(8):1090-101.

• Perz JF, Armstrong GL, Farrington LA, Hutin YJF, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;45(4):529-38.

• Waheed Y, Shafi T, Safi SZ, Qadri I. Hepatitis C virus in Pakistan: a systematic review of prevalence, genotypes and risk factors. World J Gastroenterol 2009;15(45):5647-53.

• Raja NS, Janjua KA. Epidemiology of hepatitis C virus infection in Pakistan. J Microbiol Immunol Infect 2008;41(1):4-8.

• Kinjo N, Nagao Y, Akahoshi T, Masahiro K, Hashimoto N, Uehara H, et al. Hepatic vein waveform and splenomegaly predict improvement of prothrombin time after splenectomy in hepatitis C virus-related cirrhotic patients. Hepatol Res 2013;43(9):933-41.

• Guthrie JD, Sheikh MY, Morrell S, Neal D. A case-control study to compare the likelihood of detecting liver disorders using coincident measures of doppler-derived portal vein pressure gradients, hepatic venous waveforms, and the echogenicity of liver parenchyma. J Diagn Med Sonogr 2012;28(5):211-21.

• Cosgrove D, Lassau N. Imaging of perfusion using ultrasound. Eur J Nucl Med Mol Imaging 2010;37(1):65-85

• Ahmed N, Shahid R, Tanveer S, Shafique M, Latif A. To Determine the Diagnostic Accuracy of Doppler Waveform Pattern of Hepatic Veins in Detection of Chronic Liver Disease in hepatitis C patients Keeping Histopathology as gold Standard. Pak J Radiol. 2015;25(3):89-92.

• Colli A, Cocciolo M, Riva C, Martinez E, Prisco A, Pirola M, et al. Abnormalities of Doppler waveform of the hepatic veins in patients with chronic liver disease: Correlation with histologic findings. Am J Roentgenol 1994;162(4):833-7.

• AZwiebel WJ. Sonographic diagnosis of hepatic vascular disorders. Semin Ultrasound CT MR 1995;16 (1):34–48.

• Killi RM. Doppler sonography of the native liver. Eur J Radiol 1999;32(1):21–35.

• Desser TS, Sze DY, Jeffrey RB. Imaging and intervention in the hepatic veins. AJR Am J Roentgenol 2003;180(6):1583–1591.

• Gorg C, Riera-Knorrenschild J, Dietrich J. Colour Doppler ultrasound flow patterns in the portal venous system. Br J Radiol 2002;75(899):919–929.

• Skandalakis JE, Skandalakis LJ, Skandalakis PN, Mirilas P. Hepatic surgical anatomy. Surg Clin North Am 2004;84(2):413–435.

• Zhuang ZG, Qian LJ, Gong HX. Multidetector computed tomography angiography in the evaluation of potential living donors for liver transplantation: single-center experience in China. Transplant Proc 2008;40(8):2466–2477.

• Erbay N, Raptopoulos V, Pomfret EA, Kamel IR, Kruskal JB. Living donor liver transplantation in adults: vascular variants important in surgical planning for donors and recipients. AJR Am J Roentgenol 2003;181(1):109–114.

• Nakamura S, Tsuzuki T. Surgical anatomy of the hepatic veins and the inferior vena cava. Surg Gynecol Obstet 1981;152(1):43–50.

• Mehran R, Schneider R, Franchebois P. The minor hepatic veins: anatomy and classification. Clin Anat 2000;13(6):416–421.

• Hagen-Ansert SL. Textbook of diagnostic ultrasonography. 6th ed. St Louis, Mo: Mosby Elsevier, 2006; 197.

• Kruskal JB, Newman PA, Sammons LG, Kane RA. Optimizing Doppler and color flow US: application to hepatic sonography. RadioGraphics 2004;24(3): 657–675.

• Rubin JM. Spectral Doppler US. RadioGraphics 1994;14(1):139–150.

• McGahan JP, Goldberg BB, eds. Diagnostic ultrasound: a logical approach. Philadelphia, Pa: Lippincott, 1998; 616.

• Coulden RA, Lomas DJ, Farman P, Britton PD. Doppler ultrasound of the hepatic veins: normal appearances. Clin Radiol 1992;45(4):223–227.

• Bolondi L, Li Bassi S, Gaiani S. Liver cirrhosis: changes of Doppler waveform of hepatic veins. Radiology 1991;178(2):513–516.

• Pedersen JF, Dakhil AZ, Jensen DB, Søndergaard B, Bytzer P. Abnormal hepatic vein Doppler waveform in patients without liver disease. Br J Radiol 2005;78 (927):242–244.

• Abu-Yousef MM. Duplex Doppler sonography of the hepatic vein in tricuspid regurgitation. AJR Am J Roentgenol 1991;156(1):79–83.

• Abu-Yousef MM. Normal and respiratory variations of the hepatic and portal venous duplex Doppler waveforms with simultaneous electrocardiographic correlation. J Ultrasound Med 1992;11(6):263–268.

• Teichgräber UK, Gebel M, Benter T, Manns MP. Effect of respiration, exercise, and food intake on hepatic vein circulation. J Ultrasound Med 1997;16 (8):549–554.

• Shapiro RS, Winsberg F, Maldjian C, StancatoPasik A. Variability of hepatic vein Doppler tracings in normal subjects. J Ultrasound Med 1993;12(12): 701–703.

• Roobottom CA, Hunter JD, Weston MJ, Dubbins PA. Hepatic venous Doppler waveforms: changes in pregnancy. J Clin Ultrasound 1995;23(8):477–482.

• Pekindil G, Varol FG, Yüce MA, Yardim T. Evaluation of hepatic venous pulsatility and portal venous velocity with Doppler ultrasonography during the puerperium. Eur J Radiol 1999;29(3):266–269.

• Chawla Y, Kumar S, Dhiman RK, Suri S, Dilawari JB. Duplex Doppler sonography in patients with Budd-Chiari syndrome. J Gastroenterol Hepatol 1999;14(9):904–907.

• Millener P, Grant EG, Rose S. Color Doppler imaging findings in patients with Budd-Chiari syndrome: correlation with venographic findings. AJR Am J Roentgenol 1993;161(2):307–312.

• Feldstein VA, LaBerge JM. Hepatic vein flow reversal at duplex sonography: a sign of transjugular intrahepatic portosystemic shunt dysfunction. AJR Am J Roentgenol 1994;162(4):839–841.

• Ahmed F, Coll D, Jacobson IM. Imaging. In: Schiff ER, Sorrell MF, Schiff L, Maddrey WC, eds. Schiff’s diseases of the liver. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2007; 83–126.

• Allan PL, Dubbins PA, Poznik MA, McDicken WN. Clinical Doppler ultrasound. London, England: Churchill Livingstone, 2000; 147–148.

• Oguzkurt L, Yildirim T, Torun D, Tercan F, Kizilkilic O, Niron EA. Hepatic vein Doppler waveform in patients with diffuse fatty infiltration of the liver. Eur J Radiol 2005;54(2):253–257.

• Colli A, Cocciolo M, Riva C. Abnormalities of Doppler waveform of the hepatic veins in patients with chronic liver disease: correlation with histologic findings. AJR Am J Roentgenol 1994;162(4): 833–837.

• von Herbay A, Frieling T, Häussinger D. Association between duplex Doppler sonographic flow pattern in right hepatic vein and various liver diseases. J Clin Ultrasound 2001;29(1):25–30.

• Brown BP, Abu-Yousef M, Farner R, LaBrecque D, Gingrich R. Doppler sonography: a noninvasive method for evaluation of hepatic venocclusive disease. AJR Am J Roentgenol 1990;154(4):721–724.

• Baik SK, Kim JW, Kim HS. Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology 2006;240(2): 574–580.

• Kim MY, Baik SK, Park DH. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study. Liver Int 2007;27(8):1103–1110.

• Parulekar SG, Bree RL. Liver. In: McGahan JP, Goldberg BB, eds. Diagnostic ultrasound: a logical approach. Philadelphia, Pa: Lippincott Williams & Wilkins, 1998; 676–677.

• Shiffman ML. The liver in circulatory failure. In: Schiff ER, Sorrell MF, Schiff L, Maddrey WC, eds. Schiff’s diseases of the liver. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2007; 1185–1198.

• Gorka TS, Gorka W. Doppler sonographic diagnosis of severe portal vein pulsatility in constrictive pericarditis: flow normalization after pericardiectomy. J Clin Ultrasound 1999;27(2):84–88.

• von Bibra H, Schober K, Jenni R, Busch R, Sebening H, Blömer H. Diagnosis of constrictive pericarditis by pulsed Doppler echocardiography of the hepatic vein. Am J Cardiol 1989;63(7):483–488.

• Pande AN, Lilly LS. Pericardial disease. In: Solomon SD, ed. Essential echocardiography: a practical handbook. Totowa, NJ: Humana, 2007; 191–200.

• Saad WE, Lin E, Ormanoski M, Darcy MD, Rubens DJ. Noninvasive imaging of liver transplant complications. Tech Vasc Interv Radiol 2007;10(3):191–206.

• Kok T, Slooff MJ, Thijn CJ. Routine Doppler ultrasound for the detection of clinically unsuspected vascular complications in the early postoperative phase after orthotopic liver transplantation. Transpl Int 1998;11(4):272–276.

• Choi JY, Lee JY, Lee JM. Routine intraoperative Doppler sonography in the evaluation of complications after living-related donor liver transplantation. J Clin Ultrasound 2007;35(9):483–490.

• Ko EY, Kim TK, Kim PN, Kim AY, Ha HK, Lee MG. Hepatic vein stenosis after living donor liver transplantation: evaluation with Doppler US. Radiology 2003;229(3):806–810.

• Jéquier S, Jéquier JC, Hanquinet S, Le Coultre C, Belli DC. Orthotopic liver transplants in children: change in hepatic venous Doppler wave pattern as an indicator of acute rejection. Radiology 2003;226 (1):105–112.

• Britton PD, Lomas DJ, Coulden RA, Farman P, Revell S. The role of hepatic vein Doppler in diagnosing acute rejection following paediatric liver transplantation. Clin Radiol 1992;45(4):228–232.

• Zalasin S, Shapiro RS, Glajchen N, Stancato-Pasik A. Liver transplant rejection: value of hepatic vein Doppler waveform analysis. Abdom Imaging 1998; 23(4):427–430.

• Ripoll C, Groszmann R, Garcia-Tsao G. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 2007;133:481–8.

• Mallet V, Gilgenkrantz H, Serpaggi J. Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatatis C. Ann Intern Med 2008;149: 399–403.

• Conti F, Buonfiglioli F, Scuteri A. Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. J Hepatol 2016;65:727–33.

• Anrs T, Co A, Cirvir CO. Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: data from three ANRS cohorts. J Hepatol 2016;65:734–40.

• Kumar M, Kumar A, Hissar S. Hepatic venous pressure gradient as a predictor of ¢ brosis in chronic liver disease because of hepatitis B virus. Liver Int 2008;28:690–8.

• Regev A, Berho M, Jeffers LJ. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614–18.

• de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 2015;63:543–5.

• EASL. Management of alcoholic liver disease. J Hepatol 2012;57:399–420.

• Rockey DC, Caldwell SH, Goodman ZD et al. Liver biopsy. Hepatology 2009;49:1017–44.

• Ble M, Procopet B, Miquel R. Transjugular liver biopsy. Clin Liver Dis 2014;18:767–78.

• Kalambokis G, Manousou P, Vibhakorn S. Transjugular liver biopsy: indications, adequacy, quality of specimens, and complications—a systematic review. J Hepatol 2007;47:284–94.

• Saffioti F, Pinzani M. Development and regression of cirrhosis. Dig Dis 2016;34:374–81.

• Kumar M, Sakhuja P, Kumar A. Histological subclassification of cirrhosis based on histological–haemodynamic correlation. Aliment Pharmacol Ther 2008;27:771–9.

• Tsochatzis E, Bruno S, Isgro G. Collagen proportionate area is superior to other histological methods for subclassifying cirrhosis and determining prognosis. J Hepatol 2014;60:948–54.

• Kim MY, Cho MY, Baik SK. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol 2011;55:1004–9.

• Kutami R, Girgrah N, Wanless I. The Laennec grading system for assessment of hepatic fibrosis: validation by correlation with wedged hepatic vein pressure and clinical features. Hepatology 2000;32:407A.

• Kim SU, Jung KS, Lee S. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma. Liver Int 2014;34:1008–17.

• Kim SU, Oh HJ, Wanless IR. The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis. J Hepatol 2012;57:556–63.

• Wanless IR, Nakashima E, Sherman M. Regression of human cirrhosis: morphologic features and the genesis of incomplete septal cirrhosis. Arch Pathol Lab Med 2000;124:1599–1607.

• Hytiroglou P, Snover DC, Alves V. Beyond ‘cirrhosis’ A proposal from the International Liver Pathology Study Group. Am J Clin Pathol 2012;137:5–9.

• Bosch J, Abraldes JG, Berzigotti A. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009;6:573–82.

• Llop E, Berzigotti A, Reig M. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. J Hepatol 2012;56:103–8.

• Rossle M, Blanke P, Fritz B. Free hepatic vein pressure is not useful to calculate the portal pressure gradient in cirrhosis: a morphologic and hemodynamic study. J Vasc Interv Radiol 2016;27:1130–7.

• Silva-Junior G, Baiges A, Turon F. The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique. Hepatology 2015;62:1584–92.

• La Mura V, Abraldes JG, Berzigotti A. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. Hepatology 2010;51:2108–16.

• Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol 2013;7:141–55.

• Blasco A, Forns X, Carrion JA. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology 2006;43: 492–9.

• Garcia-Tsao G, Groszmann RJ, Fisher RL. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985;5:419–24.

• Groszmann RJ, Garcia-Tsao G, Bosch J. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254–61.

• Ripoll C, Groszmann RJ, Garcia-Tsao G. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol 2009;50:923–8.

• Berzigotti A, Reig M, Abraldes JG. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology 2015;61:526–36.

• Abraldes JG, Villanueva C, Banares R. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol 2008;48:229–36.

• Rincon D, Lo Iacono O, Ripoll C. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis. Aliment Pharmacol Ther 2007;25:841–8.

• Groszmann RJ, Bosch J, Grace ND. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 1990;99:1401–7.

• Villanueva C, Balanzo J, Novella M. Nadolol plus isosorbide mononitrate compared with sclerotherapy for prevention of variceal rebleeding. N Engl J Med 1996;334:1624–9.

• Villanueva C, Minana J, Ortiz J. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;345:647–55.

• D’Amico G, Garcia-Pagan JC, Luca A. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006;131: 1611–24.

• Hernandez-Gea V, Aracil C, Colomo A. Development of ascites in compensated cirrhosis with severe portal hypertension treated with b-blockers. Am J Gastroenterol 2012;107:418–27.

• Bureau C, Alric JL, Morales J. ‘A la carte’ treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology 2002;1053:1361–6.

• Reiberger T, Ulbrich G, Ferlitsch A. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut 2013;62:1634–41.

• Merkel C, Bolognesi M, Berzigotti A. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria. J Hepatol 2010;52:45–53.

• Mandorfer M, Kozbial K, Schwabl P. Sustained virologic response to interferon-free therapies ameliorates HCVinduced portal hypertension. J Hepatol 2016;65:692–9.

• Lens S, Rincon D, Albillos A. Association between severe portal hypertension and risk of liver decompensation in patients with hepatitis C, regardless of response to antiviral therapy. Clin Gastroenterol Hepatol 2015;13:1846–53

• de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762–8.

• Rudler M, Benosman H, Lebray P. Screening for esophageal varices in patients newly diagnosed in 2011: 84% of upper gastrointestinal endoscopies are futile. Hepatology 2011;54(Suppl):935A.

• Child C, Turcotte J. Surgery and portal hypertension. In: C Child (ed.). The Liver and Portal Hypertension. Philadelphia: W. B. Saunders Co., 1964, 50.

• Lackner C, Struber G, Liegl B. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005;41:1376–82.

• Macıas J, Giron-Gonz alez JA, Gonz alez-Serrano M. Prediction of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients by simple noninvasive indexes. Gut 2006;55:409–14.

• Castera L, Le Bail B, Roudot-Thoraval F. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009;50:59–68.

• Thabut D, Imbert-Bismut F, Cazals-Hatem D. Relationship between the Fibrotest and portal hypertension in patients with liver disease. Aliment Pharmacol Ther 2007;26:359–68.

• Berzigotti A, Seijo S, Arena U. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 2013;144: 102–11.

• Sheth SG, Flamm SL, Gordon FD CS. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998;93:44–8.

• Wai CT, Greenson JK, Fontana RJ. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518–26.

• Corpechot C, Carrat F, Poujol-Robert A. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology 2012;56:198–208.

• Lok ASF, Ghany MG, Goodman ZD. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005;42:282–92.

• Procopet B, Cristea VM, Robic MA. Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension. Dig Liver Dis 2015;47:411–16.

• Corpechot C, Carrat F, Poujol-Robert A. Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis. Hepatology 2012;56:198–208.

• Sterling RK, Lissen E, Clumeck N. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43: 1317–25.

• Kim BK, Kim DY, Park JY. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int 2010;30:546–53.

• Floreani A, Cazzagon N, Martines D. Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. Dig Liver Dis 2011;43:887–92.

• Lucidarme D, Foucher J, Le Bail B. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009;49:1083–9.

• Naveau S, Gaude´ G, Asnacios A. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009;49:97–105.

• Zarski J-P, Sturm N, Guechot J. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study. J Hepatol 2012;56:55–62.

• Lichtinghagen R, Pietsch D, Bantel H. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values. J Hepatol 2013;59:236–42.

• Qamar A a, Grace ND, Groszmann RJ. Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis. Clin Gastroenterol Hepatol 2009;7:689–95.

• Kamath PS, Wiesner RH, Malinchoc M. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–70.

• Nunes D, Fleming C, Offner G. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol 2010;105:1346–53.

• Vergniol J, Foucher J, Terrebonne E. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011;140:1970–9.

• Bamber J, Cosgrove D, Dietrich CF. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 1: Basic principles and technology. Ultraschall Med 2013;34:169–84.

• Shiina T, Nightingale KR, Palmeri ML. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 1: Basic principles and terminology. UltrasoundMed Biol 2015;41:1126–47.

• Cosgrove D, Piscaglia F, Bamber J. EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: Clinical applications. Ultraschall Med 2013;34:238–53.

• Ferraioli G, Filice C, Castera L. WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 3: Liver. Ultrasound Med Biol 2015;41: 1161–79.

• Friedrich-Rust M, Ong MF, Martens S. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960–74.

• EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015;63:237–64.

• Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 2012;142: 1293–1302.

• Shi KQ, Fan YC, Pan ZZ. Transient elastography: a metaanalysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int 2013;33:62–71.

• You MW, Kim KW, Pyo J. A meta-analysis for the diagnostic performance of transient elastography for clinically significant portal hypertension. Ultrasound Med Biol 2016;43:59–68.

• Singh S, Fujii LL, Murad MH. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2013;11:1573–84.

• Castera L, Pinzani M, Bosch J. Non invasive evaluation of portal hypertension using transient elastography. J Hepatol 2012;56:696–703.

• Vizzutti F, Arena U, Romanelli RG. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007;45:1290–7.

• Friedrich-Rust M, Nierhoff J, Lupsor M. Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 2012;19:e212–19.

• 82. Feng JC, Li J, Wu XW. Diagnostic accuracy of supersonic shear imaging for staging of liver fibrosis: a meta-analysis. J Ultrasound Med 2016;35:329–39.

• Berzigotti A. (2017) Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol, Published online: February 13, 2017. DOI: 10.1016/j.jhep.2017.02.003.

• Mejias M, Garcia-Pras E, Gallego J. Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension. J Hepatol 2010;52:529–39.

• Ma X, Wang L, Wu H. Spleen stiffness is superior to liver stiffness for predicting esophageal varices in chronic liver disease: a meta-analysis. PLoS One 2016;11:1–15.

• Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging 2013;37:544–55.

• Godfrey EM, Mannelli L, Griffin N. Magnetic resonance elastography in the diagnosis of hepatic fibrosis. Semin Ultrasound CT MR 2013;34:81–8.

• Cui J, Heba E, Hernandez C. Magnetic resonance elastography is superior to acoustic radiation force impulse for the diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: a prospective study. Hepatology 2016;63:453–61.

• Imajo K, Kessoku T, Honda Y. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 2016;150:626–37.e7.

• Ronot M, Lambert S, Elkrief L. Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis. Eur Radiol 2014;24:1394–1402.

• Margini C, Berzigotti A. Portal vein thrombosis: The role of imaging in the clinical setting. Dig Liver Dis 2016;49:113–20.

• Simonovsky V. The diagnosis of cirrhosis by high resolution ultrasound of the liver surface. Br J Radiol 1999;72:29–34.

• Berzigotti A, Abraldes JG, Tandon P. Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosis. J Hepatol 2010;52:846–53.

• Gaiani S, Gramantieri L, Venturoli N. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997;27:979–85.

• Berzigotti A, Piscaglia F. Ultrasound in portal hypertension—Part 1. Ultraschall Med 2011;32:548–71.

• Berzigotti A, Piscaglia F. Ultrasound in portal hypertension—Part 2—and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension. Ultraschall Med 2012;33:8–32.

• Abraldes JG, Gilabert R, Turnes J. Utility of color Doppler ultrasonography predicting TIPS dysfunction. Am J Gastroenterol 2005;100:2696–2701.

• Brancatelli G, Federle MP, Ambrosini R. Cirrhosis: CT and MR imaging evaluation. Eur J Radiol 2007;61:57–69.

• Smith AD, Branch CR, Zand K. Liver surface nodularity quantification from routine ct images as a biomarker for detection and evaluation of cirrhosis. Radiology 2016;280:151542.

• de Franchis R. Non-invasive (and minimally invasive) diagnosis of oesophageal varices. J Hepatol 2008;49:520–7.

• McAvoy NC, Semple S, Richards JMJ. Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis. Aliment Pharmacol Ther 2016;43:947–54.

• Materne R, van Beers BE, Smith AM. Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci (Lond) 2000;99:517–25.

• Van Beers BE, Materne R, Annet L. Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrast-enhanced MRI in the rabbit. Magn Reson Med 2003;49:692–9.

• Annet L, Materne R, Danse E. Measured with MR Imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003;2:409–14.

• Gouya H, Grabar S, Vignaux O. Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2Dcine phase-contrast magnetic resonance imaging. Eur Radiol 2016;26:1981–90.

• Palaniyappan N, Cox E, Bradley C. Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging. J Hepatol 2016;65:1131–9.


Refbacks

  • There are currently no refbacks.


© Copyright PJR 2008-